🔒
Price chart and 15 days of daily prices
Candlestick chart with moving averages, Bollinger bands and MACD.
Register free to view.
Security Profile
- Security Type
- Common Stock
- CUSIP
- 74366E102
- Market Cap
- Mid Cap · $508 Million
- IPO
- 8/10/2016 · $12.00/share
Business: Protagonist Therapeutics, Inc. is a biopharmaceutical company with a proprietary technology platform focused on discovering and developing peptide-based new chemical entities to address significant unmet medical needs. Its primary focus is on developing first-in-class oral peptide drugs that specifically target biological pathways also targeted by currently marketed injectable antibody drugs.
Company Contact
- CEO
- Dinesh V. Patel, Ph.D.
- CFO
- Asif Ali
- Headquarters
- 7707 Gateway Boulevard, Suite 140 Newark CA 94560
- Phone
- 510-474-0170
- Investor Relations
- Marcy Nanus, Solebury Trout · 646-378-2927 · mnanus@soleburytrout.com